Our Research Studies
Prism Health North Texas, Inc. participates in research studies, making the medical advances of tomorrow available today.
We are honored to participate in the AIDS Clinical Trials Group, one of the largest HIV clinical trials organizations in the world.
The Research Department is currently enrolling for the following research studies:
A5332 – Randomized Trial to Prevent Vascular Events in HIV – REPRIEVE (A5332)
A5320 – Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
A5324 – A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
GSK TANGO – A Phase III, randomized, multicenter, parallel-group, noninferiority study evaluating the efficacy, safety, and tolerability of switching to dolutegravir plus lamivudine in HIV 1 infected adults who are virologically supressed
If you are interested in participating, please contact us to see if there is a study for which you might qualify. Contact: Lauren Rogers, Director of Clinical Research, 972-807-7370, ext. 4465.
Did you know…
Prism Health North Texas has been participating in research studies since 2002 and is nationally recognized for its work?